Nalaka S. Gooneratne, MD, MS
Perelman School of Medicine, University of Pennsylvania
Dr. Nalaka Gooneratne is an Associate Professor with clinical training in sleep disorders medicine, and a research focus on sleep disorders in older adults. He also serves as the Director for the Masters of Translational Research—Entrepreneurial Science track, teaches on the topic of entrepreneurship in medicine, directs the mHealth (mobile app development) service of the University of Pennsylvania Institute for Translational Medicine and Therapeutics (ITMAT), and is the PI on several NIH-funded research projects, including SBIR/STTR grants.
Rachel McGarrigle, MSEd
Perelman School of Medicine, University of Pennsylvania
Rachel McGarrigle is the Director of Education in the Perelman School of Medicine at the University of Pennsylvania. Rachel leads the education portfolio of the Institute for Translational Medicine and Therapeutics (ITMAT), designing and implementing programs to develop a workforce trained to strengthen and support the entire spectrum of translational research, from scientific discovery to improved patient care. Additionally, in her role as Director of PSOM Master’s and Certificate Programs, she supports the rapidly growing professional education opportunities at the Perelman School of Medicine. She received her Master of Science in Education, specializing in Education Entrepreneurship.
Flaura Winston, MD, PhD
Children’s Hospital of Philadelphia; Perelman School of Medicine, University of Pennsylvania
Dr. Flaura Koplin Winston is the Distinguished Chair in the Department of Pediatrics at the Children’s Hospital of Philadelphia (CHOP) and a tenured professor of pediatrics at the Perelman School of Medicine. At CHOP she is the founder and Scientific Director of the National Science Foundation Center for Child Injury Prevention Studies and the Center for Injury Research and Prevention, and she leads the CHOP Innovation Ecosystem Initiative. Her interdisciplinary background in medicine, engineering, and public health has allowed her to conduct research at the interface of child and adolescent health, injury, technology, and behavior, which led her to establish the scientific foundation dedicated to the principal cause of child death—injury—while also building and leading effective multi-stakeholder healthcare and prevention teams. Her “research-to-action-to-impact” approach to academic entrepreneurship has led to new patents, products, programs, policies, and laws, as well as a CHOP spin-out technology company called Diagnostic Driving, Inc. For her scientifically rigorous and impactful work, in 2017 she was elected to the National Academy of Medicine.
Amanda M. Ackermann, MD, PhD
Children's Hospital of Philadelphia; Perelman School of Medicine, University of Pennsylvania
Dr. Amanda Ackermann is an Assistant Professor of Endocrinology and Diabetes and a principal investigator on basic, translational, and clinical studies. Her laboratory investigates the function, genetics, and epigenetics of pancreatic beta cells to better understand why insulin secretion is dysregulated in the disorders of diabetes and congenital hyperinsulinism, in order to develop potential new treatments.
https://www.chop.edu/doctors/ackermann-amanda
Deepthi Alapati, MD
Nemours/Alfred I. duPont Hospital for Children, Sidney Kimmel Medical College of Thomas Jefferson University
Dr. Deepthi Alapati is an Attending neonatologist at Nemours AI duPont Hospital for Children and Assistant Professor of Pediatrics at Sidney Kimmel Medical College of Thomas Jefferson University. Dr. Alapati’s research is focused on translational research pertaining to neonatal lung diseases and evaluating gene editing technologies as a therapeutic tool for neonatal lung diseases.
Jacob Brenner, MD, PhD
University of Pennsylvania
Dr. Brenner is an Assistant Professor and Attending Physician at the University of Pennsylvania, in the Pulmonary, Allergy, & Critical Care Division, with a secondary appointment in Pharmacology. He received his MD and PhD at Stanford, and then completed the Stanford Biodesign fellowship. He has invented three medical devices which made it to clinical studies, with one, eclipsesystem.com, gaining de novo FDA clearance and its own CMS code. Dr. Brenner now spends 20% of his time attending in the ICU, and the other 80% developing medical technologies for his clinical specialty (http://www.brennerbioengineeringlab.com).
www.linkedin.com/in/jakebrennermdphd
Megan Brewster, MRA
Perelman School of Medicine, University of Pennsylvania
After graduating with a bachelor's degree in Biology, Megan Brewster obtained her MRA (Master of Regulatory Affairs) Degree from the University of Pennsylvania. She has focused on the study of biological products, specifically cell and gene therapies.
Ari Brooks, MD, MS
Perelman School of Medicine, University of Pennsylvania
Dr. Ari Brooks is a Professor of Surgery, the Chief of Endocrine and Oncologic Surgery and the Director of the Integrated Breast Center at Pennsylvania Hospital. He is the Clerkship Director in Surgery for the Perelman School of Medicine. He holds five patents, and has spent his career working with inventors and entrepreneurs in medical device development.
https://www.pennmedicine.org/providers/profile/ari-brooks
Jenny Cai
Bristol Myers Squibb
Jenny Cai has completed the Penn Engineering entrepreneurship certificate while currently enrolled in the Penn's Masters in Bioengineering program. She has over eight years of experience conducting clinical research, resulting in several publications in medical journals.
Vanessa Z. Chan, PhD
School of Engineering and Applied Sciences, University of Pennsylvania
Dr. Vanessa Z Chan is the Undergraduate Chair of the Materials Science & Engineering Department and the inaugural Jonathan and Linda Brassington Professor of Practice in Innovation & Entrepreneurship. She is a former partner of McKinsey & Company where she co-led their innovation practice. Prior to Penn she was an entrepreneur who invented products through her company, redesign.studio, and launched them on QVC. As well as being a professor, Dr. Chan is a partner at Robin Hood Ventures, an angel investment group where she has invested in over a dozen startups and is a board member on three companies. She is also on the Venture Board for Vanguard, Board of Trustees of the Kimmel Center and Springside Chestnut Hill Academy and President Emeritus of Elevate Network's Philadelphia Chapter.
https://www.linkedin.com/in/vanessazchan/
Barbara E. Coons, MD
Columbia University Medical Center, Department of Surgery
Dr. Barbara Coons is a surgical resident at Columbia University Irving Medical Center. She spent two years as a research fellow at the Center for Fetal Research at Children's Hospital of Philadelphia. She has a keen interest in the development of fetal therapies, research models, and novel methods of neonatal support.
https://www.linkedin.com/in/barbara-coons-284537b
Cynthia L. Dahl, JD
Penn Carey Law School, University of Pennsylvania
Cynthia Dahl is Practice Professor of Law and the founding Director of the Detkin Intellectual Property and Technology Legal Clinic at Penn Carey Law of the University of Pennsylvania. The Clinic teaches law students to be intellectual property counselors through engaging in live client work, including the startup ventures commercializing technology owned by the University of Pennsylvania. Before joining Penn Carey Law, Ms. Dahl practiced intellectual property law for fifteen years, holding positions at two national law firms as well as serving as in house counsel to several technology companies.
https://www.law.upenn.edu/cf/faculty/dahl/
Adam Dakin, MBA
DreamIt Ventures, LLC; Perelman School of Medicine, University of Pennsylvania
Adam Dakin has co-founded five healthtech companies and raised significant venture capital. Adam currently serves as the Managing Director for Dreamit Ventures, a venture fund focused on early stage healthtech, securetech, and urbantech startups. He also teaches classes on entrepreneurship at the University of Pennsylvania. He is a named inventor on seven U.S. patents.
https://www.linkedin.com/in/adamdakin
Diane K Dao, MD, MPH
University of Pennsylvania Health System
Dr. Diane Dao is an Anesthesiology and Critical Care resident at the Hospital of the University of Pennsylvania, graduating in 2021. She earned her MD/MPH from the Perelman School of Medicine and received her BA in Biological Basis of Behavior from the University of Pennsylvania. She is co-founder of Penn HealthX, a medical student organization that engages students in healthcare management, entrepreneurship, and technology. Dr. Dao is interested in quality improvement as well applications for design thinking and innovation in health care.
https://www.linkedin.com/in/diane-dao-9072b8a2/
Ryne Didier, MD
Perelman School of Medicine, University of Pennsylvania
Dr. Ryne Didier is an Attending Pediatric Radiologist at the Children's Hospital of Philadelphia and Assistant Professor at the Perelman School of Medicine at the University of Pennsylvania. She received a Certificate in Translational Research from the University of Pennsylvania Institute of Translational Medicine and Therapeutics in 2018. Her research interests involve fetal and perinatal imaging and emerging applications of contrast-enhanced ultrasound.
Benjamin J. Doranz, MBA, PhD
Integral Molecular, Inc.
Dr. Benjamin Doranz is President and CEO of Integral Molecular. Dr. Doranz co-founded the company in 2001 and has led all aspects of the company’s growth since its inception, bringing five different technologies from research to market and growing the company into a profitable commercial entity. He is an inventor on six of the company’s patents, the principal investigator on over 20 NIH grants, and an author on over 90 publications, including articles published in Cell, Science, and Nature. Dr. Doranz is an established life science entrepreneur previously responsible for directing the biotechnology program at the Port of Technology business incubator in Philadelphia and helping create startups at the Center for Technology Transfer at the University of Pennsylvania.
https://www.integralmolecular.com/company/management-team/
Nicolette Driscoll, PhD
Department of Bioengineering, University of Pennsylvania
Nicolette Driscoll earned her B.S. in Biomedical Engineering at Brown University, where she worked in a pioneering brain-computer interface (BCI) lab. Her research at Brown centered on utilizing nanomaterials to create next-generation implantable electrodes for the brain. She went on to earn a PhD in Bioengineering at the University of Pennsylvania, where she developed several implantable and epidermal sensing technologies by utilizing novel materials strategies and incorporating carbon-based nanomaterials. During her time at Penn, she also gained experience with translation and commercialization of new technologies as she produced several patents and worked with commercial entities to further her research through sponsored research agreements.
https://www.linkedin.com/in/nicolette-driscoll-43b11961/
Patrick J. Egan, JD
Children's Hospital of Philadelphia
Patrick J. Egan is Sr. Director of Compliance Operations and Conflict of Interest at Children's Hospital of Philadelphia where he oversees the institution-wide conflict of interest program. He has worked in healthcare since 2002, beginning his career at The Georgetown University School of Medicine. Prior to joining CHOP, Patrick studied law at Drexel University Kline School of Law, completing a curriculum focused on healthcare law.
Erin Esparza
Perelman School of Medicine, University of Pennsylvania
Erin Esparza works in the Clinical Cell and Vaccine Production Facility creating immunotherapy treatments for patients on clinical trials for various types of cancers as well as HIV. Ms. Esparza has a decade of experience in the field of cell therapy and is currently pursuing her Masters in Bioengineering.
https://www.linkedin.com/in/erin-esparza-6268a9168/
Ryan Fauzan, MB
Novo Nordisk A/S
Ryan Fauzan holds a Master of Biotechnology degree from the University of Pennsylvania. His study focused on biopharmaceutical products development. During his time at Penn, he served as a two-term team member of Penn Biotech Group, a student-run healthcare consulting club, and worked on cell therapy projects for pharmaceutical companies. He is an incoming Regulatory Affairs Graduate at Novo Nordisk A/S.
http://www.linkedin.com/in/ryanfsfauzan
Shelly Fehr
University of Pennsylvania
Shelly Fehr has more than 25 years of health regulatory experience. She has worked in industry and academia. She has worked with drugs, devices, foods, and cosmetics and has supported development and market programs in the US and globally.
Linda Fleisher, PhD, MPH
Fox Chase Cancer Center
Dr. Linda Fleisher is an Associate Research Professor, Health Communication and Health Disparities, Fox Chase Cancer Center and adjunct at the University of Pennsylvania Perelman School of Medicine and Thomas Jefferson University. She has over 30 years of experience in health disparities program development and research, including Co-Director of the Cancer Disparities Research Network (NCI’s GMaP Region 4) focused on supporting the career development of underrepresented investigators. She has served as the PI of an NSF funded STTR grant, NSF AWARE pilot, and a reviewer for NSF SBIR/STTR proposals.
https://www.foxchase.org/linda-fleisher
Seth Goldenberg, PhD, MS
Veeva Systems
Dr. Seth Goldenberg holds a Ph.D. in Pharmacology from the University of Washington and a M.S. from the School of Biomedical Engineering at Drexel University. In addition to his hard science background, Dr. Goldenberg previously worked at the FDA before starting up a private-equity backed consultancy in Shanghai. Dr. Goldenberg works at the intersection of academic innovators, VCs, and large corporations for the past several years in helping new products and services to market around the world with proven success in the US, EU, APAC, and Latin America. This work has focused on how to align regulatory claims, quality needs, clinical data, marketing messaging, medical communications and business KPIs for commercial success from idea to approval and beyond. He has supported companies in direct interactions with the US FDA, several notified bodies, CFDA, ANVISA, MFDS, and many other global regulatory bodies.
https://www.linkedin.com/in/seth-goldenberg-1700722/
Helge Hartung, MD
Children's Hospital of Philadelphia; Perelman School of Medicine, University of Pennsylvania"
Dr. Helge Hartung is an Assistant Professor in the Division of Hematology at The Children's Hospital of Philadelphia. He has completed the Penn Masters program in Translational Research-Entrepreneurial Sciences and is the Director of Innovation in CuRED, one of CHOP's newest Frontier programs, Dr. Hartung is interested in defining a more formal role for "physician innovators" at major academic centers such as CHOP/Penn.
Janet S. Holcombe, JD
Children's Hospital of Philadelphia
Janet S. Holcombe is Vice President, Chief Compliance and Privacy Officer at the Children's Hospital of Philadelphia (CHOP). She has overall responsibility for CHOP’s conflict of interest program and is a member of its Conflict of Interest Committee. CHOP's comprehensive COI program covers a wide range of matters including annual conflicts disclosures, research conflicts, industry interactions, and institutional conflicts.
Tomas Isakowitz, PhD
University of Pennsylvania
Dr. Tomás Isakowitz is the Program Manager of I-Corps and PCI Fellows at the Penn Center for Innovation. He is also Adjunct Faculty in Penn’s Perelman School of Medicine. Prior to PCI, Isakowitz held senior positions in Equity Research at a number of Wall Street firms. Before that, he was Assistant Professor of Information Technology at NYU’s Stern School of Business. He earned a doctorate in Computer Science from the University of Pennsylvania, a Master of Science in Mathematics from the University of California at Santa Barbara, and a Bachelor of Science in Mathematics from the Hebrew University of Jerusalem.
https://www.linkedin.com/in/tomasisakowitz/
Ramesh Iyer, MD, FRCP, FHRS
Children's Hospital of Philadelphia; Perelman School of Medicine, University of Pennsylvania
Dr. Ramesh Iyer is a Professor of Clinical Pediatrics and a Pediatric Interventional Electrophysiologist at the Children's Hospital of Philadelphia, Perelman School of Medicine. His research interests are legal aspects of health care delivery including health care fraud and cost containment.
Brian Jenssen, MD, MSHP
Children's Hospital of Philadelphia; Perelman School of Medicine, University of Pennsylvania
Dr. Brian Jenssen is a faculty member at PolicyLab at Children’s Hospital of Philadelphia (CHOP), an Assistant Professor in the Department of Pediatrics at the University of Pennsylvania, a practicing primary care pediatrician at CHOP, and Medical Director, Value-Based Care for CHOP’s Care Network (a primary care network for 260,000 pediatric patients in Pennsylvania and New Jersey). Dr. Jenssen’s research involves the use of clinical decision support systems and population health management techniques to protect children from secondhand smoke exposure and tobacco use. More broadly, he focuses on leveraging health information technology to engineer and implement novel approaches and products to improve care for children and their parents.
https://policylab.chop.edu/people/brian-jenssen
Olivia S. Jew
Perelman School of Medicine, University of Pennsylvania; The Wharton School, University of Pennsylvania
Olivia Jew is a current dual MD/MBA degree candidate at the University of Pennsylvania's Perelman School of Medicine and The Wharton School. She graduated with Honors and Phi Beta Kappa from Stanford University. Her academic interests focus on the intersection of medicine, technology, and business and investigating ways of improving access to quality care. As a board member of Penn Wharton Innovation Fund and Penn HealthX, she is dedicated to furthering academic entrepreneurship among students.
Toshitha Kannan, MS
The Wistar Institute
Toshitha Kannan works as a Bioinformatician at the Wistar Institute. She graduated from the University of Pennsylvania with a Masters in Biotechnology and graduate certificates in Engineering Entrepreneurship and Translational Research. While at Penn, she was an active member at PBG Healthcare consulting, a graduate group at Penn that does pro bono consulting for biotech and healthcare companies in the Philadelphia area where she participated as a team member, a project manager, and a project director
Julia Kelly
The Fountain Group at Merck & Co
Julia Kelly is a biology researcher currently working in the Molecular Group at Merck & Co. Her experience includes developing and performing molecular diagnostics for non-profit and start-up companies, as well as research in characterizing fungal infections.
https://www.linkedin.com/in/juliaskelly93/
Annette Krysiewicz, MB
Merck, Inc.
Annette Krysiewicz graduated with a Masters in Biotechnology from the University of Pennsylvania and also earned a Bachelors in Chemical and Biomolecular Engineering with a minor in Engineering Entrepreneurship. She is currently working at Merck as an engineer supporting development of a new facility for vaccine manufacture.
Anupam Kumar, MD, MSTR
Vanderbilt University Medical Center
Dr. Anupam Kumar is a clinical cardiology fellow at Vanderbilt University Medical Center and completed a Masters of Science in Translational Research through the Perelman School of Medicine at the University of Pennsylvania.
Tai-Yun Kuo, MB
Bon Opus Biosciences
Tai-Yun Kuo has completed a Masters of Biotechnology from the University of Pennsylvania. She has a strong interest in entrepreneurship and has supported an early-stage startup to help women reduce menstrual period pain using Chinese herbal medicines. She is currently working at a biotech startup and supporting the research community through various activities.
Sergio R. Labra, MS
Department of Chemistry, The Scripps Research Institute
Sergio R. Labra received his Bachelor of Science in Engineering and Master of Biotechnology from the University of Pennsylvania, working on Alzheimer's research at the Perelman School of Medicine. In 2018, he began his Ph.D. studies in Jeffery Kelly's lab at Scripps Research in La Jolla, CA, where he is currently developing novel in vitro human iPSC-derived models of sporadic neurodegeneration to test the therapeutic potential of pharmacologic proteostasis network regulators.
www.linkedin.com/in/sergiolabra
David S.M. Lee
Perelman School of Medicine, University of Pennsylvania
David Lee is an MD-PhD Candidate at the University of Pennsylvania working on his thesis at the intersection of genomics, genetics, and medicine. His research interests include RNA-processing, biomarker discovery, and precision oncology.
https://www.linkedin.com/in/david-sm-lee/
Mark Maloney, JD, MS
The Johns Hopkins University School of Medicine
Mark Maloney is an intellectual property professional with over 20 years of experience in patent preparation, prosecution and licensing. He is currently a director for technology licensing at Johns Hopkins University.
https://www.linkedin.com/in/markmaloneyiplawyer/
Matthew Maltese, MS, PhD
Department of Bioengineering, University of Pennsylvania
Dr. Matt Maltese is the founding Executive Director of the Pennsylvania Pediatric Medical Device Consortium. He is a part-time lecturer in the Department of Bioengineering at the University of Pennsylvania where he teaches a course on medical device development to undergraduates. He devotes his full-time effort as a founder and chief innovation officer of a medical device startup.
https://www.linkedin.com/in/matthew-r-maltese-42611713/
Scott Manaker, MD, PhD
Perelman School of Medicine, University of Pennsylvania
Dr. Scott Manaker is an actively practicing pulmonary and critical care physician in the Pulmonary and Critical Care Division at the University of Pennsylvania in Philadelphia, where he is also Professor of Medicine, Vice Chair for Regulatory Affairs for the Department of Medicine, and the Physician Advisor to the Penn Medicine Office of Billing Compliance. He has represented both the American College of Physicians (ACP) and the American College of Chest Physicians (ACCP) at the American Medical Association’s (AMA) Relative Value Unit (RVU) Update Committee (RUC) in the past, and currently chairs the RUC Practice Expense Subcommittee for the AMA. Dr. Manaker serves on the Novitas Solutions Medicare Contractor Advisory Committee for Pennsylvania, and was appointed to a second term on the Center for Medicare/Medicaid Services (CMS) Hospital Outpatient Panel (HOP) on Ambulatory Payment Classification (APC) Groups, a federal advisory committee. Dr. Manaker lectures widely across the United States as a physician advocate, speaking on chart documentation, coding, billing and reimbursement topics including the teaching physician regulations, critical care, evaluation and management coding, consultation policies, non-physician providers, and the impact of electronic medical records.
David Mankoff, MD, PhD
Perelman School of Medicine, University of Pennsylvania
Dr. David Mankoff is Gerd Muehllehner Professor of Radiology, Vice-Chair for Research in Radiology, and Director of the PET Center at the Perelman School of Medicine at the University of Pennsylvania. He also serves as the Director of the Penn Radiology Department’s PET Center and as the Associate Director for Education and Training for Penn’s Abramson Cancer Center. Dr. Mankoff is board-certified in Nuclear Medicine and holds a PhD in Bioengineering focusing on PET instrumentation. He practices Nuclear Medicine at the University of Pennsylvania, with a special interest in oncologic applications of molecular imaging and radionuclide treatment of endocrine tumors and other cancers. Dr. Mankoff’s research focuses on molecular imaging of cancer, primarily on breast cancer, and emphasizes therapeutic monitoring, identifying factors mediating therapeutic resistance, and the translation of new methods to clinical trials. He also focuses on imaging methodology and quantitative imaging methods related to molecular cancer imaging.
Alexandra M Marquez, MD, MSTR
Hospital for Sick Children, University of Toronto
Dr. Alexandra Marquez is a Clinical Associate in Pediatric Critical Care Medicine at the Hospital for Sick Children in Toronto, Canada. She completed her MD from McGill University Faculty of Medicine, residency in Pediatrics at Yale-New Haven Hospital, and Pediatric Critical Care Medicine fellowship at Children's Hospital of Philadelphia. Dr. Marquez also has a Master of Science in Translational Research from the University of Pennsylvania. Her research focuses on precision CPR and neuroprotection during resuscitation as well as device commercialization in the translational space.
Anthony Martin , MD, MSTR
Miller School of Medicine, University of Miami
Dr. Anthony Martin is an orthopaedic surgery resident at the University of Miami with an interest in biomedical device development and entrepreneurship. While a medical student, he completed engineering and healthcare entrepreneurship courses and developed a business model for the commercialization of an orthopaedic device. His future plans include partnering with institutional and industry laboratories for the development of novel surgical tools and biological treatments for common orthopaedic pathologies.
Nicola J. Mason, PhD, BVetMed
School of Veterinary Medicine, University of Pennsylvania
Dr. Nicola Mason is an Associate Professor in the Department of Clinical Sciences and Advanced Medicine and holds the Paul A. James and Charles A. Gilmore Endowed Chair Professorship at the University of Pennsylvania’s School of Veterinary Medicine. Her translational research group focuses on developing safe and effective immunotherapies for use in dogs with cancer, autoimmunity and infectious disease. Her research interests include adoptive immunotherapy using CAR T cells in canine patients with B cell malignancies, glioblastoma and metastatic OSA. Through comparative oncology her work aims to accelerate the clinical translation of effective immunotherapies, improving the lives of both humans and dogs.
Eric Max, JD
The Wharton Business School, University of Pennsylvania
Eric Max, Esq. is a Lecturer at The Wharton Business School at the University of Pennsylvania where he teaches negotiation to MBA students. Mr. Max also teaches negotiation to hundreds of business executives from around the world as part of the Wharton Executive Education Program.
https://lgst.wharton.upenn.edu/profile/emax3/
Elana Meer
Perelman School of Medicine, University of Pennsylvania
Elana Meer is a medical student at the Perelman School of Medicine at the University of Pennsylvania. As VP of curriculum at PennHealthX, she has has helped develop a novel crash course curriculum, focusing on practical applications of topics in healthcare technology and innovation from medical device design to behavioral economics in healthcare. Her research focuses on neuroeconomics and neuro-ophthalmology, investigating variations in treatment practices and outcomes. She also is currently working on 3 biomedical devices, and continues to explore how game theory applications can be utilized to improve healthcare systems and device design.
https://www.linkedin.com/in/elana-meer-b7532399
Linda L. Miller, PhD
Children's Hospital of Philadelphia
Dr. Linda Miller is the Assistant Vice President for Strategy at The Children's Hospital of Philadelphia. She received her Ph.D. in Biomedical Informatics from Stanford University. While at Stanford, Linda received a Stanford SPARK grant for her work to create a novel diagnostic tool for preeclampsia, which was spun out into a startup that was subsequently acquired by a diagnostic testing company. After her Ph.D., Linda worked as a management consultant with McKinsey & Co., where she advised pharmaceutical companies and health systems. At CHOP, Linda leads the development of enterprise and service line strategic plans, and is a member of a business plan development and approval committee.
https://www.linkedin.com/in/linda-miller-75613216/
Alexander H. Morrison, MD, MSTR
Department of Medicine, Perelman School of Medicine, University of Pennsylvania
Dr. Alex Morrison is a Neurology resident at the University of Pennsylvania. Along with his MD, he completed a Master of Science in Translational Research at the University of Pennsylvania in 2019, during which he studied immune therapies in a murine model of pancreatic cancer with a focus on clinical translation. He serves on the Board of Directors for Sling Health, a non-profit biotechnology incubator that provides resources, training, and mentorship to teams of students developing innovative solutions to clinical problems.
Mauricio Novelo
Perelman School of Medicine, University of Pennsylvania
Mauricio Novelo is the Senior Software Engineer and Project Director for the mHealth Service at the Perelman School of Medicine at the University of Pennsylvania. Having developed multiple mobile apps for a variety of clinical research studies, he is now channelling his expertise through his role as key architect of mPhenomic, an open-source, operating system agnostic, biomedical research platform that facilitates communication between research subjects and investigators and near-real-time, remote data collection for longitudinal studies. His research interests lie in leveraging modern and emerging technologies to make clinical research more streamlined and accessible.
https://www.linkedin.com/in/mauricionovelo/
Bike Su Oner
Clinical Cell and Vaccine Production Facility, University of Pennsylvania
Bike Su Oner is a Manufacturing Resource Technologist at the Cell and Vaccine Production Facility at the University of Pennsylvania, which manufactures cellular therapies for Phase 1 clinical trials. Having worked in translational research studies for the past 6 years, she focuses on process improvements specifically with respect to time efficiency and reduction of human errors. Currently, she is enrolled in a bioengineering masters degree program at Penn where her thesis focuses on processes required to bring promising new academic discoveries to patients.
Natalie Oppenheimer
Children's Hospital of Philadelphia
Natalie Oppenheimer is a Program Coordinator with the Center for Injury Research and Prevention where she manages various projects within the Neuroscience of Driving research program. She is also the coordinator of CHOP’s Innovation Ecosystem team whose mission is to facilitate cohesion among CHOP’s innovation hubs, and help innovators and innovative ideas to move further and faster through the organization. She is currently pursuing a Master’s Certificate in Biomedical Informatics at the University Of Pennsylvania Perelman School Of Medicine.
Sunghee E. Park, MS
Department of Bioengineering, University of Pennsylvania
Estelle Park is currently a PhD candidate in bioengineering program at Penn. Her research focuses on developing organ-on-a-chip to study pathophysiology of various diseases.
Neil Patel, MD, MSTR
University of California San Francisco
Dr. Neil Patel is interested in the intersection of business and medicine. He is a graduate of the Roy and Diana Vagelos Program in Life Sciences & Management Program, which is a dual-degree curriculum between the Wharton School and College of Arts & Sciences at the University of Pennsylvania. He then worked at Strategy& (formerly Booz & Company), as a management consultant specializing in healthcare strategy. He obtained his M.D. and Masters of Science in Transnational Research (M.T.R.) degrees at the University of Pennsylvania, before he started his specialty training in Otolaryngology Head & Neck Surgery at the University of California San Francisco.
https://www.linkedin.com/in/neil-n-patel-7b97a223/
Yvonne Paterson, PhD
Perelman School of Medicine, University of Pennsylvania
Dr. Yvonne Paterson is Professor of Microbiology at the University of Pennsylvania. Her research is in the field of cancer immunotherapy. She is the inventor of a vaccine approach that harnesses the abilities of a bacterium, Listeria monocytogenes, and its products, to induce potent immunity. This approach has won many awards including the World Vaccine Congress’ Best Therapeutic Vaccine in 2012, the Medical Visionary Award from the Farrah Fawcett Foundation in 2015, and the Vision of Hope award from the Sarcoma Foundation of America in 2016. Dr. Paterson has over 40 U.S. patents, and numerous international patents, licensed to Advaxis Immunotherapies Inc., which she founded in 2002. Dr. Paterson is a fellow of the National Academy of Inventors, the American Academy of Microbiology, the American Association for the Advancement of Science and she was selected in 2014 for inclusion in PharmaVoice’s 100 Most Inspiring People in the Life-Sciences Industry.
https://micro.med.upenn.edu/faculty/?key=p19034
Claire M. Phoumyvong, MB
Department of Pharmacology, Northwestern University Feinberg School of Medicine
Claire Phoumyvong received her Bachelor's in Biology and Master's in Biotechnology at the University of Pennsylvania. She is currently a research technician in the Rocklin Lab at Northwestern Feinberg School of Medicine. She is particularly interested in the intersection of medicine and technology and hopes to apply both those fields in her future doctoral studies. Her past work has involved developing small molecules in cancer, and she is always eager to learn about translating innovations in the lab to therapeutics.
Prima Pisuttisarun, MB
IQVIA
Prima Pisuttisarun is a graduate of the University of Pennsylvania's Master's in Bioengineering program. At Penn, she was actively involved in the Penn Wharton Entrepreneurship's community and worked with early-stage start-ups in digital health and biotechnology. Prior to this, she graduated from the University of California, Los Angeles (UCLA) with a degree in Biochemistry. Ms. Pisuttisarun is currently working as an associate consultant for IQVIA's predictive analytics team, driving machine learning solutions to identify rare diseases patients and further develop AI applications in healthcare. www.fairps.com
Mohit Prajapati, MBA, MS
University of Pennsylvania Health System
Mohit Prajapati is the director of research and development, strategy, and operations for the Acceleration Lab at the Penn Medicine Center for Health Care Innovation. In this role, he works to leverage novel innovations from health care startups into measurable impact as it relates to improved patient care, improved quality, and cost reductions. Via the center’s Medical Device Accelerator, Mohit helps University of Pennsylvania faculty and clinicians transform basic research and clinical insights into products that deliver on unmet clinical needs. Prior to joining this team, Mr Prajapati worked in the medical device industry for almost 13 years. Notable roles include co-founder of Cérventis, product development engineer at Aesculap, and director of engineering at Terray Corporation. He has been responsible for leading cross-functional research and development teams - taking products from initial concept to commercial launch. Mohit’s portfolio of products includes proprietary spinal fusion constructs with minimally invasive approaches, novel biomimetic implants with bone matching mechanical properties, and new fracture fixation devices. Mr. Prajapati is the author of several U.S. and international patents. He holds a bachelor’s degree in biomedical engineering and a Master’s degree in Engineering specializing in non-invasive strain measurement of orthopaedic soft tissue from the University of Guelph in Guelph, Ontario, Canada, as well as a Master’s degree in Business Administration from Queen’s University School of Business in Kingston, Ontario, Canada.
https://healthcareinnovation.upenn.edu/bio/mohit-prajapati-msc-mba
Abhinay Ramachandran
Perelman School of Medicine, University of Pennsylvania
Abhinay Ramachandran is an MD/Master of Science in Translational Research candidate at the Perelman School of Medicine at the University of Pennsylvania. His training has included a degree in bioengineering, a minor in healthcare management, and internships with a research lab, healthcare organization, and medical device company. He looks to combine his passion for patient care with interests in translational medical device advances to improve diagnostics, therapeutics, and access to healthcare.
https://www.linkedin.com/in/abhinay-ramachandran-4349b945/
Maureen W. Rinkunas, MS, MBA
DuPont Ventures
Maureen (Moe) Rinkunas, principal at DuPont Ventures, drives collaboration with the external innovation community via tech scouting and venture deal sourcing and supports due diligence, proof of concept & proof of value trials, development of term sheets, and post-deal portfolio management. Most recently, she was the Platform Director for Dreamit Ventures, where she led sourcing and acceleration of both pre- and post-seed startups across multiple industry track, conducted early due diligence for the investment team, and oversaw corporate partnership programs aimed at bringing both startups and the entrepreneurial mindset to large organizations. Over the past 15 years, Ms. Rinkunas has worked with hundreds of teams at organizations of all sizes from startups to Fortune 500 companies to help them take ideas from conception to market. She has both a BS and MS in Chemical Engineering, as well as an MBA in Corporate Entrepreneurship, all from Lehigh University.
https://www.linkedin.com/in/mwrinkunas/
Roy Rosin, MBA
Penn Medicine
Roy Rosin is Chief Innovation Officer at Penn Medicine, working to redesign health care delivery. His team has driven measurable progress in readmission rates, medication adherence, behavioral health, opioid management, screening rates, and guiding patients to optimal, high value care settings, while also helping incubate a broad range of early stage companies. Previously, Mr. Rosin served as the first VP of Innovation for Intuit, a leading software company best known for Quicken and TurboTax and now consistently appearing on Forbes' list of most innovative companies in the world after delivering shareholder returns well above the S&P 500. Prior to leading innovation, Mr. Rosin’s Quicken team achieved record profitability and product leadership while growing to 14 million consumers. Mr. Rosin's 18 years with Intuit spanned the early years in software to their emergence as a leading SaaS provider. He received his MBA from Stanford and graduated with honors from Harvard College.
Sarah Rottenberg, MA
University of Pennsylvania
Sarah Rottenberg is an Adjunct Assistant Professor at the University of Pennsylvania Stuart Weitzman School of Design and the Executive Director of the Integrated Product Design Program, a master's program at Penn that brings together design, business, and engineering. Sarah specializes in bringing people together to design products, experiences, and businesses that are desirable, meaningful, feasible, and viable.
Richard Sensenig, MS
Department of Surgery, Cooper University Hospital
Richard Sensenig is a physicist and electrical engineer who worked 31 years for the U.S. Navy managing research and development projects for anti-submarine warfare. Since retiring from the civil service, he has worked with the surgery departments of several medical institutions in the development of medical research programs. He has also worked as a grants/contracts consultant for Operative Experience, Inc. in the submission and management of government grants to develop operative models for surgical education and training.
Swapnil Shewale, MS, PhD
University of Pennsylvania, Cardiovascular Institute
Dr. Swapnil V Shewale is the Technical Director of the Cardiovascular Mouse Phenotyping Core at the University of Pennsylvania. Dr. Shewale has an MS and PhD in Physiology and Pharmacology and conducted his post-doctoral fellowship in cardiovascular genetics and physiology of cardio-metabolic diseases at Penn. He previously served as a Senior Technology Transfer fellow at Wake Forest Innovations and has experience in innovation commercialization and academic entrepreneurship. https://www.med.upenn.edu/cvi/mouse-cardiovascular-phenotyping-core/
Pallab Singh, JD, PhD
Riverside Law, LLP
Dr. Pallab Singh has over ten years of experience working on the commercialization and patent protection of technologies in the fields of biologics, biotechnology, bioengineering and medical devices. He earned a Ph.D. in bioengineering from the University of Pennsylvania in 2011, where he investigated the neuronal response to traumatic brain injury. During his graduate work, Dr. Singh worked at the Center for Technology Transfer at the University of Pennsylvania where he performed technology assessments and conducted patentability evaluations of university technologies. Since 2011, he has worked as a patent agent at Riverside Law and has experience in patent preparation and prosecution, patent strategy, portfolio management and due diligence. He earned his law degree (summa cum laude) from Temple University Beasley School of Law in 2019. During his studies, Dr. Singh was selected as a Microsoft Fellow and received the Robert C. Podwil Memorial Prize for excellence in academic performance in intellectual property.
Jeremy S. Solomon
Self-Employed
Jeremy Solomon is an alumnus of Drexel University's Close School of Entrepreneurship, where he studied health innovations, social entrepreneurship, and international developmental economics. Mr. Solomon also brings field experience, having co-authored the commercialization plan of one software company and having designed the spec sheet blueprint for another. His background centers around ethical behaviors within the field of entrepreneurship and decision making in a commercial environment.
https://www.linkedin.com/in/jeremy-solomon-907a37151/Michael Sosnowski
Insights & Research Consultant
Michael Sosnowski has more than 25 years of experience in consumer research and insight generation, helping organizations to gather relevant data and use it to solve fundamental questions of strategy and practical marketing problems. In every instance the underlying challenges have been the same -- to substitute information for guesswork and hunches, to find the compelling story in the data, and to tell that story clearly and convincingly so as to build consensus and make effective decisions. He currently is an independent Insights & Research Consultant, and before that was an Executive Vice President and Partner at TRC Market Research.
Gauri Srivastava, MS
IQVIA, Inc.
Gauri Srivastava has a Master of Biotechnology degree and an engineering entrepreneurship certificate from the University of Pennsylvania. She has a strong interest in the drug industry and learned about the regulatory policies, management as well as drug discovery, in order to be well versed with different aspects of the industry. She has previously worked with start-up companies and with the Penn Biotechnology Group (PBG), where she was a consultant on two projects involving orphan drugs. She is currently working with IQVIA as an Analyst to provide consulting services to pharmaceutical and biotech companies.
https://www.linkedin.com/in/gauri-srivastava-581394b4/
Elliot Stein, MD, MSTR
Pennsylvania Hospital, University of Pennsylvania
Dr. Elliot J. Stein is an internal medicine resident at Pennsylvania Hospital who is going into radiology residency at the University of California-San Francisco. He has an interest in device development and translational science as it pertains to the field of interventional radiology. He completed his Master of Science in Translational Research (MSTR) degree with a project investigating the development of a novel percutaneous electrolytic liver tumor ablation device, which included initial prototyping, in vitro validation, in vivo device development and experimentation, and formation of a spin out start-up company from a lab. He is a graduate of the University of Pennsylvania School of Medicine and Harvard College.
Joy Sun
Capital One
Joy Sun is a graduate of the University of Pennsylvania. She studied biochemistry and has worked with multiple startups as internships throughout college, including a biomedical device startup. This entrepreneurial work, along with her lab research experience, led to her leadership in the Healthcare Entrepreneurship committee within the Wharton Undergraduate Healthcare Club. Through this committee, she taught her peers the latest in medical device advancements and connected students with various healthcare and biomedical startups local to the Philadelphia region.
Zev Sunleaf
Children's Hospital of Philadelphia
Zev Sunleaf is Vice President, Technology Transfer, Innovation, and Research Contracts at Children's Hospital of Philadelphia Research Institute. CHOP is dedicated to bringing breakthroughs to children through research, innovation and commercialization.
Prior to joining CHOP, Mr. Sunleaf was Executive Director of the University of Iowa Research Foundation. Before joining the research foundation, Mr. Sunleaf was vice president at Caviforce Technologies, Inc., and Solltech, Inc., both located in Coralville. He is a graduate of the University of Iowa.
Brett Topche
Red & Blue Ventures
Brett Topche co-founded Red & Blue Ventures and has more than a decade and a half of venture capital and private equity experience. He has spent much of his career primarily focusing on investments in ecommerce, digital media, mobile applications, marketing technologies and B2B software. Prior to co-founding Red & Blue, he spent more than nine years at MentorTech Ventures. He previously spent time at Hamilton Lane Advisors and NJTC Venture Fund.
Jason P. Van Batavia, MD
Children's Hospital of Philadelphia; Perelman School of Medicine, University of Pennsylvania
Dr. Jason P. Van Batavia is an attending pediatric urologist at Children's Hospital of Philadelphia and Assistant Professor of Urology in Surgery at the University of Pennsylvania School of Medicine. In addition to his clinical work, he is currently completing his Master of Science in Translational Research (Entrepreneurial Science Concentration) from the University of Pennsylvania, which is supported by a KL2 grant. As part of this program, Dr. Van Batavia has been involved in developing innovative pediatric medical devices in pediatric urology, work that has been supported by an FDA grant, and has led to local business partnerships.
https://www.chop.edu/doctors/van-batavia-jason
Ping Wang, PhD, DABCC, FAACC
Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania.
Dr. Ping Wang is currently the Chief of Clinical Chemistry and Director of Core Laboratory at the Hospital of the University of Pennsylvania (HUP), and Associate Professor of Pathology and Laboratory Medicine at the University of Pennsylvania. Dr. Wang’s research focuses on developing novel and high-performing technologies to fulfill unmet needs in disease diagnosis, prognosis and monitoring, with novel sensors, materials and devices. Her work is funded by government agencies and industrial partners. She also works with and advises major diagnostic companies and start-ups to commercialize technologies she invented.
https://www.med.upenn.edu/apps/faculty/index.php/g275/p8934699
Maura Weber, MSE
ETHOS Health Communications
Maura Weber completed her undergraduate degree in the Biological Basis of Behavior at the University of Pennsylvania and transitioned into full time neurotrauma research following graduation as a technician in Dr. Douglas H. Smith's laboratory. She completed her Masters in Bioengineering at Penn under the supervision of Victoria E. Johnson and studied the effects of trauma on the cerebrovasculature. She currently works as a Strategic Account Associate at ETHOS Health Communications, a medical communications agency which specializes in interpreting and communicating the science of medicine.
James Weimer, PhD
University of Pennsylvania
Dr. James Weimer is faculty in the Department of Computer and Information Science at the University of Pennsylvania and in the Department of Biomedical and Health Informatics at the Children’s Hospital of Philadelphia. His research interests include the design and analysis of cyber-physical systems with application to medical devices/monitors. He serves as an associate editor of the ACM Transaction on Cyber-Physical Systems and has earned the best paper award and been a best paper finalist at the International Conference on Cyber-Physical Systems (ICCPS) in 2014 and 2015, respectively. His entrepreneurship activities include founding Neuralert Technologies, a start-up focused on wearable solutions for detecting in-clinic neurological events including stroke.
https://www.seas.upenn.edu/~weimerj/
Ashley R. Winslow, PhD
Orphan Disease Center, Perelman School of Medicine, University of Pennsylvania
Dr. Ashley Winslow is Senior Director of Translational Research & Portfolio Development at the Orphan Disease Center (ODC) at the University of Pennsylvania. In her current role, Dr. Winslow focuses on strategies to address critical gaps in drug development for rare disease by developing innovative solutions and partnerships with international rare disease communities. Primary areas of focus for the Center are international patient registries, enabling access to disruptive technologies, funding promising research, and helping foundations and families jump-start their own research portfolio. Dr. Winslow received her PhD in Medical Genetics from the University of Cambridge and completed her postdoctoral work at Massachusetts General Hospital and Harvard Medical School. Before joining the ODC, Dr. Winslow was Associate Director of Neurogenetics in the Human Genetics and Computational Biomedicine group at Pfizer where she oversaw use and interpretation of human-derived data across R&D, from target discovery to early clinical programs.
www.linkedin.com/in/arwinslow
Fabiana Zappala, BS
Department of Bioengineering, University of Pennsylvania
Fabiana Zappala is an MIT graduate with a BS in Chemical Engineering. She is a Bioengineering PhD student at Penn, and her thesis focuses on immuno-oncology. Her career goals include combining science and entrepreneurship. She is a Technology Transfer Fellow at the Penn Center for Innovation and a Business Advisor student fellow at the University of Science QED Proof-of-Concept incubator.
https://www.linkedin.com/in/fabiana-zappala/